BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Policy

  Vanda Pharmaceuticals Weighs Options Following Failed Legal Battle with FDA

  Following a court’s ruling last week over a partial clinical hold placed on the company in 2018 by the U.S. Food and Drug Administration, Vanda Pharmaceuticals said it is undertaking a “comprehensive review” of the decision and will then determine the next appropriate steps.

  February 4, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Experimental HIV Vaccine Proves Ineffective in Study, NIH Says

  The National Institutes of Health ceased administration of an investigational HIV vaccine after interim data revealed that the treatment was not working in preventing the virus.

  February 4, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Lone Star Bio

  CARB-X Funds Development of Rapid Diagnostic for Drug-Resistant Bacterial Infection

  Pattern Bioscience was awarded funding from CARB-X to develop a new rapid diagnostic for drug-resistant bacterial infection.

  February 4, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Ideas for Cultivating Diversity and Inclusion in the Workplace

  Your organization needs to figure out how to come up with ideas for cultivating diversity and inclusion in the workplace.

  February 4, 2020

   · 

  4 min read

   · 

  Don Potochny
• 

  International Team Develops Promising Broad-Spectrum Antiviral Compound

  “We have successfully engineered a new molecule, which is a modified sugar that shows broad-spectrum antiviral properties,” said Samuel Jones, from The University of Manchester.

  February 4, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  BioMotiv and Bristol-Myers Squibb Launch Anteros Pharma

  “Anteros Pharmaceuticals is the first of several companies that BioMotiv and Bristol-Myers Squibb intend to form under the Strategic Partnership Agreement,” said Satish Jindal, BioMotiv’s chief executive officer.

  February 4, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  French Authorities Investigate Sanofi Over Birth Defects Linked to Depakine

  The active component of the drug, sodium valproate, has been on the market for epilepsy and bipolar disorder since 1967.

  February 4, 2020

   · 

  2 min read

   · 

  Mark Terry
• Business

  Profound Medical Retires Bank Debt Ahead of Schedule

  Profound Medical Corp. announced that it has retired its $12.5 million in principal amount loan with Canadian Imperial Bank of Commerce, maturing on July 29, 2022.

  February 4, 2020

   · 

  4 min read
• Policy

  FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic

  The U.S. Food and Drug Administration issued an emergency use authorization to enable emergency use of the Centers for Disease Control and Prevention’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel.

  February 4, 2020

   · 

  5 min read
• Deals

  Integra Announces Pricing of Convertible Senior Notes - Feb. 04, 2020

  Integra LifeSciences Holdings Corporation announced the pricing of $500,000,000 aggregate principal amount of 0.5% convertible senior notes due 2025.

  February 4, 2020

   · 

  9 min read